Carlo Tascini

32PUBLICATIONS
244CO-AUTHORS
Nanotoxicology, health and safetyMedical bacteriologyMedical infection agents (incl. prions)PharmacogenomicsMedical microbiology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Jul 25, 2026
Oritavancin as consolidation or suppressive therapy in infective endocarditis and device-related infections: real-world experience with therapeutic drug monitoring.

|May 28, 2026
Case Commentary: When susceptibility is not enough in recurrent Burkholderia cenocepacia infection.

|Mar 13, 2026
Current opinion on the potential role of liposomal amphotericin B in underexplored clinical scenarios.

Jacopo Angelini, Sara Ferin, Luca Martini

|Feb 27, 2026
Target Fidelity and Failure: Structure-Activity Relationship of High-Molecular-Mass Penicillin-Binding Proteins (HMM-PBPs) in Refractory Granulicatella adiacens Endocarditis.

Paola Conti, Alberto Pagotto, Sebastiano A Fortuna

|Feb 20, 2026
Optimizing target inactivation to treat multidrug-resistant Escherichia coli with NDM and PBP3 mutations: "going the extra mile".

Claudia Fabrizio, Felice Valzano, Simone Giuliano

|Dec 30, 2025
In Vitro Evaluation of Fosfomycin Combinations Against Metallo-β-Lactamase-Producing Klebsiella pneumoniae and Pseudomonas aeruginosa Clinical Isolates.

Esther Wohlfarth, Aurélien Dinh, Georgia Vrioni

Pageof 6

Frequent Collaborators

5 joint publications

Simone Giuliano

4 joint publications

Livio Pagano

4 joint publications

Jon Salmanton-García

4 joint publications

Francesca Farina